» Authors » Xiaoyong Qi

Xiaoyong Qi

Explore the profile of Xiaoyong Qi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 217
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ni Y, Cao J, Li Y, Qi X
Exp Cell Res . 2025 Jan; 445(1):114422. PMID: 39805338
SRY-Box Transcription Factor-11 (SOX11) is a transcriptional regulatory factor that plays a crucial role in inflammatory responses. However, its involvement in atherosclerosis (AS), a cardiovascular disease driven by endothelial cell...
2.
Liu H, Zhang F, Li Y, Liu L, Song X, Wang J, et al.
Coron Artery Dis . 2024 Nov; PMID: 39492724
Introduction And Objective: Despite recent advances in the management of ST-segment elevation myocardial infarction (STEMI), the clinical outcome of some patients is still unsatisfactory. Therefore, early evaluation to identify high-risk...
3.
Wang J, Yin Y, Lu C, Lu Z, Hu J, Wang Y, et al.
EClinicalMedicine . 2024 May; 72:102626. PMID: 38756107
Background: Previous trials of renal denervation (RDN) have been designed to investigate reduction of blood pressure (BP) as the primary efficacy endpoint using non-selective RDN without intraoperatively verified RDN success....
4.
Gao M, Zhang F, Xie Y, Li J, Hao X, Liu H, et al.
Medicine (Baltimore) . 2023 Nov; 102(45):e35823. PMID: 37960808
Rationale: Apical hypertrophic cardiomyopathy (ApHCM) is a phenotypic variant of hypertrophic cardiomyopathy. Endomyocardial fibrosis and endocardial calcification are especially rare in ApHCM. Patient Concerns: The main symptoms was chest tightness,...
5.
Wang J, Zhang F, Liu L, Gao M, Song X, Li Y, et al.
Angiology . 2023 Nov; :33197231213674. PMID: 37936386
The Global Registry of Acute Coronary Events (GRACE) score and the systemic immune-inflammation index (SII) were used independently to predict adverse outcomes in patients with ST-elevation myocardial infarction (STEMI). In...
6.
Qi L, Chen J, Li X, Qi X, Ding C, Chen X, et al.
Front Cardiovasc Med . 2022 Sep; 9:888604. PMID: 36072875
Background: To evaluate the safety and efficacy of hybutimibe plus atorvastatin for lipid control in hypercholesterolemia patients with atherosclerotic cardiovascular disease risk equivalent. Methods: In this double-blind phase III study,...
7.
Chen X, Yang Q, Bai W, Yao W, Liu L, Xing Y, et al.
Front Pharmacol . 2022 Jun; 13:873108. PMID: 35645838
Recent studies have shown that sodium-glucose cotransporter-2 (SGLT2) inhibitors play a beneficial role for normoglycemic patients with heart failure (HF). However, the underlying mechanism remains largely unexplored. In the present...
8.
Xu Y, Hu Y, Geng Y, Zhao N, Jia C, Song H, et al.
Aging (Albany NY) . 2022 May; 14(9):4036-4049. PMID: 35522573
Background: HF is a common complication of MI. The underlying mechanisms of myocardial fibrosis in HF after MI are incompletely defined. Here, this study aims to investigate the role of...
9.
Wang Y, Liu L, Li X, Dang Y, Li Y, Wang J, et al.
J Interv Cardiol . 2022 Mar; 2022:8994106. PMID: 35356419
Background: Mortality after percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients with cardiogenic shock (CS) remains high. However, the real-world risk factors for mortality in these patients are...
10.
Cao J, Ni Y, Zhang H, Ning X, Qi X
Exp Anim . 2022 Mar; 71(3):356-367. PMID: 35321971
Rheumatoid arthritis (RA) is an autoimmune disease, which can lead to joint inflammation and progressive joint destruction. Kruppel-like factor 7 (KLF7) is the member of KLF family and plays an...